WT1-specific donor-derived T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for WT1-specific donor-derived T cells, covering 2025-03-20 to 2025-03-20. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma [Phase 1]